DEFIANCE DAILY TARGET 2X LONG HIMS ETF(HIMZ)

POST19.440.01+0.05%19:59 EDT

19.43-1.49-7.12%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- Hims & Hers Health: Customer Medical Records Were Not Impacted by This Incident, Neither Were Communications With Health Care Providers on Platform
  THOMSON REUTERS · 05:38
  Hims & Hers Health: Customer Medical Records Were Not Impacted by This Incident, Neither Were Communications With Health Care Providers on Platform
- Hims & Hers Health Inc: on Mar 3, Identified Personal Information Related to Limited Set of Individuals Present in Affected Service Tickets
  THOMSON REUTERS · 05:38
  Hims & Hers Health Inc: on Mar 3, Identified Personal Information Related to Limited Set of Individuals Present in Affected Service Tickets
- Hims & Hers Health: in Response, Co Undertook a Review of Affected Service Tickets to Determine What Information Was Present & to Whom It Relates
  THOMSON REUTERS · 05:38
  Hims & Hers Health: in Response, Co Undertook a Review of Affected Service Tickets to Determine What Information Was Present & to Whom It Relates
- Hims & Hers Health Inc: Offering Complimentary Credit Monitoring & Identity Restoration Services for 12 Months Through Cyberscout
  THOMSON REUTERS · 05:38
  Hims & Hers Health Inc: Offering Complimentary Credit Monitoring & Identity Restoration Services for 12 Months Through Cyberscout
- Hims & Hers Health: on Feb 5, Became Aware of Suspicious Activity Affecting Our Third-Party Customer Service Platform
  THOMSON REUTERS · 05:38
  Hims & Hers Health: on Feb 5, Became Aware of Suspicious Activity Affecting Our Third-Party Customer Service Platform
- BRIEF-Telehealth Giant Hims & Hers Says Its Customer Support System Was Hacked - TechCrunch
  Reuters · 05:28
  BRIEF-Telehealth Giant Hims & Hers Says Its Customer Support System Was Hacked - TechCrunch
- US FDA clarifies policies on compounding of GLP-1 medicines
  Reuters · 04-02 04:07
  US FDA clarifies policies on compounding of GLP-1 medicines
- Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US
  Reuters · 03-31
  Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US
- BRIEF-Novo Nordisk Announces New Multi-Month Subscription Program For Wegovy For Eligible Self-Pay Patients
  Reuters · 03-31
  BRIEF-Novo Nordisk Announces New Multi-Month Subscription Program For Wegovy For Eligible Self-Pay Patients
- Novo Nordisk: Wegovy Pill 9 Mg, 25 Mg Doses Subscription Plans for 3-Months at $289/Month, 6-Months at $269/Month, 12-Months at $249/Month
  THOMSON REUTERS · 03-31
  Novo Nordisk: Wegovy Pill 9 Mg, 25 Mg Doses Subscription Plans for 3-Months at $289/Month, 6-Months at $269/Month, 12-Months at $249/Month
- Novo Nordisk: Wegovy Subscription Program to Be Available From Mar 31 Through Ro, Weightwatchers, LifeMD
  THOMSON REUTERS · 03-31
  Novo Nordisk: Wegovy Subscription Program to Be Available From Mar 31 Through Ro, Weightwatchers, LifeMD
- Option traders moderately bearish in Hims and Hers Health with shares down 3.43%
  TIPRANKS · 03-31
  Option traders moderately bearish in Hims and Hers Health with shares down 3.43%
- Hims & Hers Health Is Maintained at Hold by TD Cowen
  Dow Jones · 03-27
  Hims & Hers Health Is Maintained at Hold by TD Cowen
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS) and Siemens Healthineers AG (OtherSEMHF)
  TIPRANKS · 03-27
  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS) and Siemens Healthineers AG (OtherSEMHF)
- HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise
  TIPRANKS · 03-27
  HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise
- Hims & Hers GLP-1 subscription fee slightly higher than expected, says BofA
  TIPRANKS · 03-27
  Hims & Hers GLP-1 subscription fee slightly higher than expected, says BofA
- Hims & Hers Health to Sell Wegovy, Ozempic, Launch Weight-Loss Membership
  Dow Jones · 03-27
  Hims & Hers Health to Sell Wegovy, Ozempic, Launch Weight-Loss Membership
- BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & Hers
  Reuters · 03-27
  BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & Hers
- Novo Nordisk’s FDA-Approved Glp-1S NOW Available With Hims & Hers
  THOMSON REUTERS · 03-27
  Novo Nordisk’s FDA-Approved Glp-1S NOW Available With Hims & Hers
- Hims & Hers Health Inc - Introduces Weight Loss Membership Starting at $39 First Month, $149 After
  THOMSON REUTERS · 03-27
  Hims & Hers Health Inc - Introduces Weight Loss Membership Starting at $39 First Month, $149 After
Company Profile
Company Name
DEFIANCE DAILY TARGET 2X LONG HIMS ETF
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
- -
Zip Code
- -
Phone
- -
Fax
- -
Introduction
- -

1D
5D
Day
Week
Month

Loading ...

High

20.09

Open

20.00

Volume%

0.95

Low

18.63

20.92

T/O Rate

25.33%

To The Moon

DEFIANCE DAILY TARGET 2X LONG HIMS ETF(HIMZ)

Company Profile

Most Discussed